Initiate studies to develop minimally invasive biomarkers for detection of cerebral amyloidosis, AD, and related dementias pathophysiology.
Development and testing of 5 biomarkers that utilize biofluids or other minimally invasive imaging, electrophysiological recording, or other methodologies to assess the burden of AD and ADRD pathophysiology that could be used in community based and epidemiological studies of AD and related dementias.
2015 to 2019
Research Implementation Area
B. Diagnosis, Assessment and Disease Monitoring
Activities, Funding Initiatives, and Resources
Funded Research Projects
IADRP – Category B. Diagnosis, Assessment and Disease Monitoring - 1. Fluid Bio…
IADRP – 2. Imaging Biomarkers
NIH PAR-15-359: Novel Approaches to Diagnosing Alzheimer's Disease & Predicting…
NIH RFA-AG-15-011: Biomarkers of Alzheimer’s Disease in Down Syndrome (R01) – R…